Abstract
The metabolism of the new nootropic drug unifiram is considered; this drug supposedly has significantly higher activity than that of piracetam, and it is under clinical trials as a means of improving memory and preventing Alzheimer’s disease, attention-deficit disorder, and various forms of dementia. The structures of two potential metabolites of unifiram are proposed. Based on the interpretation of the experimental mass spectra of precursor ions and product ions, the applicability of a non-target screening methodology with the use of ultra-high performance liquid chromatography–high-resolution mass spectrometry to the detection of these compounds was demonstrated. It was established that the supposed metabolites of unifiram can be determined only with the use of enzymatic hydrolysis, while mineral hydrolysis led to the complete destruction of both the unifiram itself and the hypothetical metabolites. The use of the proposed chromatographing and mass-spectrometric detection conditions makes it possible to detect unifiram metabolites within six days after a single administration of 10 mg of the substance.
Similar content being viewed by others
REFERENCES
Guandalini, L., Martino, M.V., Di Cesare Mannelli, L., Bartolucci, G., Melani, F., Malik, R., Dei, S., Floriddia, E., Manetti, D., Orlandi, F., Teodori, E., Ghelardini, C., and Romanelli, M.N., Bioorg. Med. Chem. Lett., 2015, vol. 25, no. 8, p. 1700.
Martini, E., Norcini, M., Ghelardini, C., Manetti, D., Dei, S., Guandalini, L., Melchiorre, M., Pagella, S., Scapecchi, S., Teodori, E., and Romanelli, M.N., Bioorg. Med. Chem. Lett., 2008, vol. 16, no. 23, p. 10034.
Martino, M.V., Guandalini, L., Di Cesare Mannelli, L., Menicatti, M., Bartolucci, G., Dei, S., Manetti, D., Teodori, E., Ghelardini, C., and Romanelli, M.N., Bioorg. Med. Chem. Lett., 2017, vol. 25, no. 6, p. 1795.
Mondadori, C., Ducret, T., and Hausler, A., Psychopharmacology, 1992, vol. 108, nos. 1–2, p. 11.
Galeotti, N., Ghelardini, C., Pittaluga, A., Pugliese, A.M., Bartolini, A., Manetti, D., Romanelli, M.N., and Gualtieri, F., Arch. Pharmacol., 2003, vol. 368, no. 6, p. 538.
Mondadori, C., Life Sci., 1994, vol. 55, nos. 25–26, p. 2171.
Malik, R., Gupta, R., Srivastava, S., and Choudhary, B.S., J. Biomol. Struct. Dyn., 2016, vol. 35, no. 11, p. 2382.
Giurgea, C. and Salama, M., Prog. Neuro-Psychopharmacol., 1977, vol. 1, nos. 3–4, p. 235.
Gouliaev, A.H. and Senning, A., Brain Res. Rev., 1994, vol. 19, no. 2, p. 180.
Schindler, U., Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 1989, vol. 13, p. 99.
Romanelli, M.N., Galeotti, N., Ghelardini, C., Manetti, D., Martini, E., and Gualtieri, F., CNS Drug Rev., 2006, vol. 12, no. 1, p. 39.
Mondadori, C., Petschke, F., and Häusler, A., Pharmacopsychiatry, 1989, vol. 22, p. 102.
Mondadori, C., Behav. Brain Res., 1993, vol. 59, nos. 1–2, p. 1.
Malik, R., Sangwan, A., Saihgal, R., Jindal, D.P., and Piplani, P., Curr. Med. Chem., 2007, vol. 14, no. 2, p. 123.
Gualtieri, F., J. Enzyme Inhib. Med. Chem., 2015, vol. 31, no. 2, p. 187.
Dmitrieva, E.V., Temerdashev, A.Z., Azaryan, A.A., and Gashimova, E.M., Analitika Kontrol’, 2018, vol. 22, no. 1, p. 28.
Peters, F.T. and Meyer, M.R., Drug Test. Anal., 2011, vol. 3, nos. 7–8, p. 483.
Wank, J., Wagner-Redeker, W., Taylor, A., Herbold, R., and Lassahn, P.-G., High-resolution, accurate mass measurements and metabolite identification: An automated approach using fragment prediction in combination with fragment ion search (FISh), Thermo Fisher Scientific Application, note 537, 2016.
De Bruyn Kops, C., Stork, C., Sicho, M., Kochev, N., Svozil, D., Jeliazkova, N., and Kirchmair, J., Front. Chem., 2019, vol. 7, no. 402, p. 1.
Funding
This study was supported by the Ministry of Education and Science of the Russian Federation (project no. FZEN-2020-0022) and the Russian Foundation for Basic Research (project no. 19-43-230004 r_а) and carried out with the participation of specialists from the Environmental and Analytical Center of the Kuban State University (unique identifier RFMEFI59317Х0008).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated by V. Makhlyarchuk
Rights and permissions
About this article
Cite this article
Temerdashev, A.Z., Zorina, M.O., Dmitrieva, E.V. et al. A Study of the Metabolism of the New Nootropic Preparation Unifiram by Ultra-High Performance Liquid Chromatography–High-Resolution Mass Spectrometry. J Anal Chem 76, 204–211 (2021). https://doi.org/10.1134/S1061934821020131
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1061934821020131